Loading data
BRZENasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 738.18 m USD | 593.41 m USD | 471.8 m USD | 355.43 m USD | 238.04 m USD |
| Cost of revenue | 242.53 m USD | 183.19 m USD | 147.53 m USD | 115.82 m USD | 78.51 m USD |
| Gross profit | 495.66 m USD | 410.22 m USD | 324.27 m USD | 239.61 m USD | 159.52 m USD |
| Research and development expense | 167.14 m USD | 133.97 m USD | 119.86 m USD | 97.29 m USD | 59.03 m USD |
| Operating profit | -144.76 m USD | -122.16 m USD | -144.69 m USD | -148.14 m USD | -78.21 m USD |
| Profit before tax | -128.16 m USD | -100.6 m USD | -128.47 m USD | -140.16 m USD | -78.33 m USD |
| Income tax expense | 2.63 m USD | 3.45 m USD | 1.96 m USD | 583 k USD | -165 k USD |
| Net income (reported basis) | -131.29 m USD | -103.74 m USD | -129.17 m USD | -138.97 m USD | -78.17 m USD |
| Basic earnings per share | -1.22 USD/share | -1.02 USD/share | -1.32 USD/share | -1.47 USD/share | -2.2 USD/share |
| Diluted earnings per share | -1.22 USD/share | -1.02 USD/share | -1.32 USD/share | -1.47 USD/share | -2.2 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.